Patent · US Active

Chemical compounds

US9814699B2 · kind B2 · utility

0Cited by
27References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 10, 2016
Grant dateNov 14, 2017
Priority date
Expiry dateFeb 10, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are compounds of Formula III. Also disclosed are salts of the compounds, pharmaceutical composition comprising the compounds or salts, and methods for treating HCV infection by administration of the compounds or salts.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.